Dysregulation of the HGF/c-MET signaling cascade can lead to tumorigenesis by transforming normal cells into tumor cells and c-MET hyperactivation has been reported in cancers including lung cancer, colorectal cancer, glioblastoma, and acute myeloid lymphoma among others13,14. This evidence concerns the gene MET and cancer.